Close Menu
    What's Hot

    Kosmos Management Completes Maple Life Financial Acquisition

    5 August 2025

    Japan Post Insurance Invests in Global Atlantic Vehicle

    31 July 2025

    US Annuity Sales Set New Record in First Half of 2025

    29 July 2025
    X (Twitter) LinkedIn
    LinkedIn X (Twitter)
    Life Risk News
    • Home
    • Features

      Significant Growth Potential in Equity Release/Reverse Mortgage Market but Change is Required to Get There

      16 July 2025

      Insurance Capacity Boost and Growth in Small Deals Mark Busy First Half in UK Pension Risk Transfer Market

      16 July 2025

      Life Settlement Population Outlook Suggests Underwriting Frameworks Will Need to Continue to Adjust

      16 July 2025

      Q&A: Perry Koons, Director of Capital Markets, Maple Life Financial

      16 July 2025

      Nuanced Impact of CMI Model Change on Pension Risk Transfer Market

      16 July 2025
    • Commentary

      Mental Health Illness and Its Impact on Life Expectancy in the USA

      16 July 2025

      The Dangers of Defaulting to Fast Track

      16 July 2025

      Life Expectancy in Breast Cancer

      12 June 2025

      The Healthy Wealthy Population of the Life Settlement Market

      12 June 2025

      UK Life Insurers to Benefit from Robust Bulk Annuity Market in 2025

      14 May 2025
    • Events
    • Magazine
    • News

      Kosmos Management Completes Maple Life Financial Acquisition

      5 August 2025

      Japan Post Insurance Invests in Global Atlantic Vehicle

      31 July 2025

      US Annuity Sales Set New Record in First Half of 2025

      29 July 2025

      New Paper Offers Insights Into How Best To Shape the Future of the Risk Transfer Process

      29 July 2025

      British Heart Foundation Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      29 July 2025
    Subscribe
    Life Risk News
    Home » Life Settlement Population Outlook Suggests Underwriting Frameworks Will Need to Continue to Adjust

    Life Settlement Population Outlook Suggests Underwriting Frameworks Will Need to Continue to Adjust

    Features 16 July 2025Greg WintertonBy Greg Winterton
    Twitter LinkedIn Email
    Share
    Twitter LinkedIn Email

    According to a recent article in InsuranceNewsNet, The Life Mortality Improvement Subgroup of the Society of Actuaries’ (SoA) Mortality and Longevity Oversight Advisory Council (MLOAC) is seeking to switch from general population data to insured population data as an input into its mortality modelling effort. 

    The reason cited in the article is because, despite the similarities in the data at age cohorts lower than 80, “insured population mortality improvement sharply drops” after that. 

    A change in approach by an actuarial body is hardly new; as the understanding of mortality evolves, as must the models. Indeed, the UK’s Continuous Mortality Investigation made the most significant changes to its model in many years just this year, the result of a lengthy feedback process among participants. Pension schemes and insurers in Britain all use the CMI model as a fundamental input into their own approaches. 

    But, if the SoA does make the change, how much of an impact will this have on life expectancy (LE) forecasts in the life settlement market? 

    Little, because of the approach that some in the space already take. 

    “Many life settlement LE providers already rely heavily on their own proprietary, insured-population tables tailored to the life settlement cohort. They are not likely to change underwriting practices because of any changes to the general population mortality tables,” said Liam Bodemeaid, Actuarial Consultant at Actuarial Risk Management (ARM). 

    The life settlement cohort is, in the grand scheme of insured populations, small. In 2023, 3,181 transactions closed the secondary market, compared with 9.5 million new life insurance policies issues in the USA in the same year. 

    That is not comparing apples to apples, as the latter includes all age cohorts. But still, it illustrates the small size of the life settlement market when compared to the overall space. Additionally, mortality nuances permeate the life settlement group which are a root cause of the aforementioned tailored approach that some life expectancy providers take – with a notable trend emerging. 

    “There are important distinctions between the general and life settlement populations. Life settlement insureds tend to come from higher socio-economic groups, they are typically wealthier, more educated, and have greater access to quality healthcare,” said Bodemeaid. 

    “And the longevity gap between high and low-income groups has only widened in recent years, with evidence suggesting improved mortality outcomes among life settlement cohorts.” 

    The nature of underwriting insureds in the life settlement market – in the sense that life expectancy predictions are very specific to the individual – also means that comorbidities have a significant impact on any given insured’s projection. According to Bodemeaid, this reinforces a reason why a LE provider in the market is likely to be influenced less by a change in a broader dataset. 

    “In life settlements, mortality must be assessed on an impairment-specific basis. Medical advancements progress unevenly; some impairments see breakthrough treatments sooner than others. So, applying blanket adjustments risks introducing distortions into underwriting,” he said. 

    There is another reason why life expectancy data for the life settlement cohort differs from the general population. In primary life insurance, selection occurs after policy issuance when insureds need to prove they are of an acceptable health at underwriting. This means that mortality is lower for an insured who recently took out a policy compared to someone else of the same gender, age and smoking status who took out their policy several years beforehand, generally. Not so in life settlements. 

    “The inverse is true in life settlements, in that insureds generally need to prove impairment to receive their settlement amounts. Therefore, the structure of the mortality tables between these two population subsets needs to be inherently different and is another reason why LE underwriters use bespoke life settlement mortality tables to underwrite on the secondary and tertiary markets,” said Bodemeaid. 

    But despite the comparatively smaller cohort of insureds that the life settlement market deals with, one interesting thought experiment could be in whether pension plan sponsors and life insurers could use the data that the life settlement market has to tweak their mortality modelling even further. 

    That is because the life settlement market is regularly underwriting American Seniors, whereas the life insurance industry is not. And not every policy that comes to market is purchased by an investor or warehouser, so LE underwriters have much more data than the 3,000 or so policies that are sold on the secondary market each year – especially since these insureds are re-underwritten as and when their policies transact in the tertiary life settlement market. 

    Still, if there was to be a ‘mortality table’ for the life settlement market specifically, it could well show additional gains over the coming years thanks to a list of emerging trends. 

    AI-driven medical innovation – the acceleration of drug discovery, diagnosis, and personalised treatment pathways – is just one. The targeting of the biology of ageing and the increasing take-up of weight loss and metabolic drugs are two others. 

    “The life settlement population, by virtue of wealth and education, has more access to cutting-edge diagnostics, and generally follows more proactive and preventive health regimes. And as sequencing costs drop and datasets grow, therapies tailored to an individual’s genetic profile will become increasingly common and high-net-worth individuals are more likely to benefit early from this next wave of healthcare personalisation,” said Bodemeaid. 

    “While these developments may not change actuarial assumptions overnight, they reinforce the need for underwriting frameworks to evolve with the times. They also present a long-term risk to mortality assumptions, particularly in life settlement portfolios with an older, affluent, and health-engaged insured base.” 

    2025 - July Life Settlements Longevity Risk Secondary Life Markets Volume 4 Issue 7 – July 2025
    Share. Twitter LinkedIn Email

    Related Posts

    Significant Growth Potential in Equity Release/Reverse Mortgage Market but Change is Required to Get There

    16 July 2025

    Insurance Capacity Boost and Growth in Small Deals Mark Busy First Half in UK Pension Risk Transfer Market

    16 July 2025

    Q&A: Perry Koons, Director of Capital Markets, Maple Life Financial

    16 July 2025

    Nuanced Impact of CMI Model Change on Pension Risk Transfer Market

    16 July 2025

    Comments are closed.

    Most Popular

    Significant Growth Potential in Equity Release/Reverse Mortgage Market but Change is Required to Get There

    16 July 2025

    Insurance Capacity Boost and Growth in Small Deals Mark Busy First Half in UK Pension Risk Transfer Market

    16 July 2025

    Life Settlement Population Outlook Suggests Underwriting Frameworks Will Need to Continue to Adjust

    16 July 2025

    Mental Health Illness and Its Impact on Life Expectancy in the USA

    16 July 2025
    Ad

    Your trusted source for capital markets participation in Life Risk

    X (Twitter) Instagram LinkedIn
    Life Risk
    • About Life Risk News
    • Get In Touch
    • Our Team
    • Copyright Notice
    • Terms and Conditions
    • Privacy Policy
    • Sitemap
    Coverage
    • Home
    • Features
    • Events
    • Commentary
    Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT